| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xilio Therapeutics, Inc. (XLO) has 5 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. XLO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 88.5K | $791.2K | - | |
| Other | 33.3K | $297.3K | - | |
| CFO | 24.8K | $221.4K | - | |
| Dir | 10.0K | $89.4K | - | |
| VP | 6.4K | $57.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | Rivervest Venture Fund Iv, L.P. | 10% Owner | Buy | 250,000 | $16.00 | $4,000,000.00 | +21.0% | -12.5% | -86.4% | |
| Oct 26, 2021 | Bay City Capital LLC | 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +38.3% | -12.5% | -86.4% | |
| Oct 26, 2021 | Rock Springs Capital Management LP | 10% Owner | Buy | 500,000 | $16.00 | $8,000,000.00 | +66.1% | -12.5% | -86.4% | |
| Oct 26, 2021 | Atlas Venture Fund Xi, L.P.53 | 10% Owner | Buy | 187,500 | $16.00 | $3,000,000.00 | +34.2% | -12.5% | -86.4% |